Here are the most clinically significant terms and keywords extracted from the guideline, organized by relevance and section:  

### **General Protocol Information**  
- **Retained placenta**  
- **Incidence: 1:100 - 200 births**  
- **Recurrence rate: 8-10%**  
- **Active management (30-minute threshold)**  
- **Physiological management (60-minute threshold)**  

### **Causes of Retained Placenta**  
- **Trapped separated/partially separated placenta**  
- **Full bladder**  
- **Uterine atony**  
- **Constriction ring**  
- **Uterine abnormality**  
- **Morbidly adherent placenta (1 in 1500 births)**  
  - **Placenta accreta / increta / percreta**  

### **Immediate Management (No Active Bleeding)**  
- **Labour ward coordinator notification**  
- **Consent for active management**  
- **Bladder catheterization (indwelling catheter)**  
- **Breastfeeding to encourage uterine contraction**  
- **Upright positioning / walking to toilet**  
- **Unclamp umbilical cord (allow drainage)**  
- **Homebirth → hospital transfer**  
- **Obstetric registrar notification**  
- **IV access (16G venflon)**  
- **Blood tests (group & save, FBC, U&Es)**  
- **IV crystalloid (Hartmann’s / 0.9% NaCl)**  
- **Vital signs monitoring (BP, pulse q15min)**  
- **Nil by mouth (NBM)**  
- **Avoid IV oxytocin if no bleeding**  
- **Manual removal under regional/general anesthesia**  

### **Immediate Management (Active Bleeding)**  
- **Oxytocin infusion (40U in 50ml NaCl at 12.5ml/hr)**  
- **Manual removal in theatre**  
- **Consent for procedure (Obstetric registrar/SHO)**  
- **Crossmatch 2 units blood**  
- **Anaesthetist notification**  
- **PPH (postpartum hemorrhage) proforma**  
- **Theatre team alert**  
- **Accurate fluid balance (MIS, blood loss tracking)**  
- **Prophylactic IV Cefuroxime**  

These terms encapsulate the critical clinical actions, diagnostic criteria, and management steps for retained